@inproceedings{inproceedings, title  = {{Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Final results for the AVAST-M trial.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{http://eprints.whiterose.ac.uk/131249/ }},

 year = {{2017}},

 month = {{5}},

 author = {{Corrie P and Marshall A and Lorigan P and Gore ME and Tahir S and Faust G and Kelly CG and Marples M and Danson S and Marshall E and Houston S et al}},

 doi = {{10.1200/jco.2017.35.15_suppl.9501}},

 volume = {{35}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{9501-9501}},

 note = {{Accessed on 2024/12/26}}}